The Latest Data Impacting Immuno-oncology Combinations and Patient Treatment
Perspectives Representing Science, Clinical and Business

The 4th annual IO Combinations 360° program addresses clinical advancements, scientific data and business aspects in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.

IO Combinations 360° Delivers Three Key Benefits:

1. Access to KOLs driving the science
2. Partnership opportunities with all stakeholders in Immuno-Oncology & Combinations
3. Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology Combinations